| Trial Identifier: | D6450C00001 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT03889275 |
| Start Date: | October 2019 |
| Primary Completion Date: | November 2021 |
| Study Completion Date: | December 2022 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation |
| Country | Location |
|---|---|
| ES | Barcelona, ES, 8035 |
| ES | Madrid, ES, 28027 |
| GB | Guildford, GB, GU2 7WG |
| GB | Leeds, GB, LS9 7TF |
| GB | London, GB, SW3 6JJ |
| US, AZ | Phoenix, AZ, US, 85054 |
| US, CA | La Jolla, CA, US, 92093 |
| US, MN | Rochester, MN, US, 55905 |
| US, NC | Chapel Hill, NC, US, 27599 |
| US, NY | Buffalo, NY, US, 14263 |
| US, NY | New York, NY, US, 10065 |
| US, PA | Pittsburgh, PA, US, 15232 |
| US, RI | Providence, RI, US, 02903 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company